Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

28 та иш

Иш: Modeling an active conformation for linear peptides and design of a competitive inhibitor for HMG‐CoA reductase

  1. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

    Marion M. Bradford

    Мақола197659 иқтибос
    ABI

  2. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding

    Mark A. Bradford

    Мақола197640 иқтибос
    ABI

  3. Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model

    Michael J. S. Dewar, Eve G. Zoebisch, Eamonn F. Healy +1

    Мақола198517 иқтибос
    ABI

  4. Isolation and Identification of Peptides from Soy 11S-Globulin with Hypocholesterolemic Activity

    Valeriy V. Pak, Minseon Koo, T. D. Kasymova +1

    МақолаProtein Hydrolysis and Bioactive PeptidesChemistry of Natural Compounds200514 иқтибос
    ABI

  5. Statin inhibition of HMG-CoA reductase: a 3-dimensional view

    Eva S. Istvan

    Шарҳ мақола200313 иқтибос
    ABI

  6. Structure—Activity Relationships of the Peptide Ile-Ala-Val-Pro and Its Derivatives Revealed Using the Semi-Empirical AM1 Method

    Valeriy V. Pak, Minseon Koo, N. Lee +2

    Мақола200512 иқтибос
    ABI

  7. Amino Acid Substitution of Hypocholesterolemic Peptide Originated from Glycinin Hydrolyzate

    Dae Young Kwon, Si Won Oh, Ji Soo Lee +5

    Мақола200211 иқтибос
    ABI

  8. Conformation Analysis of Ile-Ala-Val-Pro Peptide and Its Derivatives by Circular Dichroism

    Valeriy V. Pak, Minseon Koo, Dae Young Kwon +1

    МақолаChemical Synthesis and AnalysisChemistry of Natural Compounds200411 иқтибос
    ABI

  9. Advances and Continuing Challenges in Achieving Realistic and Predictive Simulations of the Properties of Organic and Biological Molecules

    Peter A. Kollman

    Мақола199611 иқтибос
    ABI

  10. Peptide design of a competitive inhibitor for HMG‐CoA reductase based on statin structure

    Valeriy V. Pak, Sung Hee Kim, Minseon Koo +3

    МақолаComputational Drug Discovery MethodsBiopolymers200610 иқтибос
    ABI

  11. Geometric versus topological clustering: An insight into conformation mapping

    Oren M. Becker

    Мақола19979 иқтибос
    ABI

  12. Conformer Profiles and Biological Activities of Peptides

    J. W. Payne, N. Justin Marshall, Barry M. Grail +1

    Мақола20028 иқтибос
    ABI

  13. Protein secondary structure and circular dichroism: A practical guide

    W. Curtis Johnson

    Шарҳ мақола19908 иқтибос
    ABI

  14. Recognized sequence and conformation in design of linear peptides as a competitive inhibitor for HMG‐CoA reductase

    Valeriy V. Pak, Minseon Koo, L. M. Yun +1

    МақолаComputational Drug Discovery MethodsJournal of Molecular Recognition20078 иқтибос
    ABI

  15. Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total Mortality

    Patricia R. Hebert

    Мақола19977 иқтибос
    ABI

  16. HBTU activation for automated Fmoc solid-phase peptide synthesis.

    Cynthia G. Fields, Donna Lloyd, Robyn L. Macdonald +2

    Мақола19926 иқтибос
    ABI

  17. Flexibility, Conformation Spaces, and Bioactivity

    Oren M. Becker, Yaakov Levy, Orr Ravitz

    Мақола20006 иқтибос
    ABI

  18. Correcting the Circular Dichroism Spectra of Peptides for Contributions of Absorbing Side Chains

    Chartchai Krittanai, W. Curtis Johnson

    Мақола19976 иқтибос
    ABI

  19. Conformational interconversions in peptide β-turns: analysis of turns in proteins and computational estimates of barriers 1 1Edited by J. Thornton

    Kannan Gunasekaran, L. Gomathi, C. Ramakrishnan +2

    Мақола19986 иқтибос
    ABI

  20. The discovery and development of HMG-CoA reductase inhibitors.

    Akira Endo

    Мақола19926 иқтибос
    ABI

  21. Cholesterol Lowering in the Management of Coronary Artery Disease: The Clinical Implications of Recent Trials

    Daniel A. Eisenberg

    Шарҳ мақола19986 иқтибос
    ABI

  22. Binding effect and design of a competitive inhibitory peptide for HMG-CoA reductase through modeling of an active peptide backbone

    Valeriy V. Pak, Minseon Koo, Min Jung Kim +2

    МақолаComputational Drug Discovery MethodsBioorganic & Medicinal Chemistry20076 иқтибос
    ABI

  23. Structural Mechanism for Statin Inhibition of HMG-CoA Reductase

    Eva S. Istvan, J. Deisenhofer

    Мақола20016 иқтибос
    ABI

  24. 9-Fluorenylmethoxycarbonyl amino-protecting group

    Louis A. Carpino, Grace Han

    Мақола19725 иқтибос
    ABI

  25. SOLID‐PHASE PEPTIDE SYNTHESIS USING MILD BASE CLEAVAGE OF <i>N</i><sub>α</sub>FLUORENYLMETHYLOXYCARBONYLAMINO ACIDS, EXEMPLIFIED BY A SYNTHESIS OF DIHYDROSOMATOSTATIN

    Chi‐Deu Chang, Johannes Meienhofer

    Мақола19784 иқтибос
    ABI